Steinmetz Anke, Yvorra Thomas, Retailleau Pascal, Lantz Olivier, Schmidt Frédéric
Centre de Recherche et Développement Vitry-Alfortville, IDD/ISDD, Sanofi-Aventis R&D, Vitry-surSeine, 94400, France.
Institut Curie, PSL University, CNRS UMR3666, INSERM U1143, Paris, 75005, France.
Data Brief. 2020 Dec 29;34:106704. doi: 10.1016/j.dib.2020.106704. eCollection 2021 Feb.
Data of molecular dynamics (MD) simulations were obtained for mucosal-associated invariant T (MAIT) cell ligands complexed with MR1 or MR1/TCR. Ligands included in the simulations were natural ligands 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU), 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil (5-OP-RU), their C5' ethinylated analogs in S or R configuration, as well as the corresponding fluorophore-reacted products. All-atom models of the binary and ternary complexes were constructed using PDB entry 4NQE and docked poses [1]. Missing loops, N- and C-termini were completed by homology modelling, the loop conformations optimized, and the models energy minimized prior to setup for MD simulations. A standard pre-equilibration protocol was applied before the production phase of 120 ns simulation as NPT ensemble at 300 K and 1 atm applying an explicit solvent model with OPLS3 force field parameters. Atomic coordinates and energies were recorded every 60 ps and 12 ps, respectively. The corresponding raw data files of the MD simulations are part of this dataset. All simulations were analysed with respect to root mean square deviations (rmsd) and root mean square fluctuations (rmsf) of the coordinates of protein and ligand atoms, stability of protein secondary structure, protein-ligand contacts, ligand torsion profiles, and ligand properties. More detailed statistics of non-covalent interaction counts were also collected. Radial distribution functions (rdf) were calculated when relevant. Visualization of the trajectories permits appreciation of the molecular dynamics of both, ligands and proteins and their interactions, thereby supporting drug design of MAIT cell ligands; furthermore, additional analysis of e.g. conformational changes or interactions not reported in the primary publication [1] can be performed on the data. The raw data may also be used as starting point for extension of the simulations or more sophisticated MD techniques.
获得了与MR1或MR1/TCR复合的黏膜相关恒定T(MAIT)细胞配体的分子动力学(MD)模拟数据。模拟中包括的配体有天然配体5-(2-氧代亚乙基氨基)-6-D-核糖基氨基尿嘧啶(5-OE-RU)、5-(2-氧代丙基亚乙基氨基)-6-(D-核糖基氨基)尿嘧啶(5-OP-RU)、它们具有S或R构型的C5'乙炔化类似物,以及相应的荧光团反应产物。使用PDB条目4NQE和对接姿势构建二元和三元复合物的全原子模型[1]。缺失的环、N端和C端通过同源建模完成,环构象优化,模型能量在进行MD模拟设置之前最小化。在120 ns模拟的生产阶段之前,应用标准的预平衡协议,以NPT系综在300 K和1 atm下进行,应用具有OPLS3力场参数的显式溶剂模型。原子坐标和能量分别每60 ps和12 ps记录一次。MD模拟的相应原始数据文件是该数据集的一部分。所有模拟均针对蛋白质和配体原子坐标的均方根偏差(rmsd)和均方根波动(rmsf)、蛋白质二级结构的稳定性、蛋白质-配体接触、配体扭转轮廓和配体性质进行了分析。还收集了非共价相互作用计数的更详细统计数据。在相关时计算径向分布函数(rdf)。轨迹的可视化允许了解配体和蛋白质的分子动力学及其相互作用,从而支持MAIT细胞配体的药物设计;此外,可以对数据进行例如主要出版物[¹]中未报道的构象变化或相互作用的额外分析。原始数据也可作为模拟扩展或更复杂MD技术的起点。